The p53 tumor suppressor gene encodes a sequence-specific transcription factor (E1- Deiry et al. 1992; Zambetti et al. 1992) . p53 is frequently mutated in human tumors (for review, see Harris and Hollstein 1993) , leading to the loss of its DNA-binding and/or trans-activation properties {Farmer et al. 1992; Kern et al. 1992; Zambetti and Levine 1993) . Recent studies suggest that transcriptional activation by p53 accounts for its tumor suppressor function (Pietenpol et al. 1994) . The finding that transcription of the Cdk inhibitor WAF1, a key player in cell cycle arrest, is activated by p53 (E1- Deiry et al. 1993 ) strongly supports this notion.
The activity of p53 is potentiated in normal cells following DNA damage (Maltzman and Czyzyk 1984; Kastan et al. 1991 Kastan et al. , 1992 Kuerbitz et al. 1992; Fritsche et al. 1993; Lu and Lane 1993; Zhan et al. 1993) . This is achieved, at least in part, through stabilization of the otherwise labile p53 protein, which leads to the accumulation of considerable amounts of p53 and stimulates the activation of its transcriptional targets. The enhanced biochemical activity of p53 may culminate in either 1Corresponding author. growth arrest or apoptosis, two processes that can be evoked experimentally by overexpressed wild-type p53 (Diller et al. 1990; Mercer et al. 1990; Michalovitz et al. 1990; Gannon and Lane 1991; Martinez et al. 1991; Yonish-Rouach et al. 1991) . The determinants that dictate the choice between growth arrest and apoptosis in response to p53 activation are poorly understood at the moment; the extent of the damage and the repair capacity of the cells, as well as availability of survival signals, may play a role in the final decision.
The mdm2 proto-oncogene was originally isolated by virtue of its amplification in a tumorigenic derivative of NIH-3T3 cells (Cahilly-Snyder et al. 1987; Fakharzadeh et al. 1991) . Amplification of mdm2 has since been documented in an array of human malignancies (Oliner et al. 1992; Ladanyi et al. 1993; Leach et al. 1993; Reifenberger et al. 1993; Cordon-Cardo et al. 1994) . The oncogenic properties of the mdm2 gene product have been attributed to its interaction with the p53 protein (Barak and Oren 1992; Momand et al. 1992; Oliner et al. 1992; Barak et al. 1993; Finlay 1993) , an interaction that inhibits the biochemical activities of the latter (Momand et al. 1992; Oliner et al. 1993; Zauberman et al. 1993) . It was therefore surprising to discover that the mdm2 gene is Cold Spring Harbor Laboratory Press on February 5, 2014 -Published by genesdev.cshlp.org Downloaded from actually activated by p53 Otto and Deppert 1993; Wu et al. 1993 ). This finding has been taken to imply that mdm2 is a component of a negative feedback loop whereby p53, once having fulfilled its biochemical tasks, activates mdm2 whose product in turn renders p53 inactive Picksley and Lane 1993; Wu et al. 1993) . Activation of the mdm2 gene by p53 involves the physical interaction of p53 with two imperfect response elements located within the first intron of this gene Wu et al. 1993) . Interestingly, transfection experiments have indicated that a small genomic DNA fragment encompassing these two p53 response elements {p53 REs) can exhibit p53-dependent promoter activity when coupled to a reporter gene .
We now report that this activity is attributable to the existence of a functional p53-responsive promoter within the first intron of the murine mdm2 gene. This promoter (P2) gives rise to distinct transcripts, which lack the entire first exon and a few nucleotides from the second exon of murine mdm2. Moreover, P2 is activated by p53 not only in artificial reporter plasmids but also within the context of the endogenous, chromosomal mdm2 gene. Transcription from P2 appears to be strongly p53-dependent, whereas transcription from the upstream, constitutive mdm2 promoter (P1) is only mildly induced, if at all, by excess wild-type p53. The sequence of these two types of mdm2 transcripts predicts that they should encode identical products. Nevertheless, conditions could be found where synthetic RNA molecules corresponding to each transcript gave rise to distinct in vitro translation profiles, with varying proportions of p53-binding and nonbinding MDM2 proteins. These data imply that p53, through the activation of an alternative promoter, can potentially modulate both the amount and the nature of the MDM2 proteins, thereby adding a further dimension to the complex interaction between these two growth regulators.
Results
The 5' end of the p53-dependent mdm2 transcript is located within exon 2
Using chimeric reporter plasmids, we demonstrated previously that p53 can induce transcription from a murine mdm2 genomic DNA fragment lacking the 5'-flanking sequences of the gene. This observation could imply the existence of a putative internal promoter {P21, located within this fragment. This promoter could potentially be associated with the two p53 REs identified within the first intron of the mouse mdm2 gene . The minimal internal mdm2 genomic DNA fragment that still exhibits p53-dependent promoter activity is an ApaI-NsiI -400-bp fragment, encompassing the 3' part of intron 1, the entire exon 2, and the 5' half of intron 2 ; see also Fig. 1AI . A transcript emanating from P2 will therefore lack exon 1 but may include exon 3 and possibly sequences from intron 1 and/or exon 2 or altematively intron 2 {see Fig. 1A ). We wished to determine whether overexpression of wild-type p53 gives rise to a discrete transcript initiated within this fragment and to compare the structure of such transcript with that of the full-length mdm2 eDNA characterized previously (Fakharzadeh et al. 1991) . To that end, RNase protection analysis was performed using an antisense eDNA-derived riboprobe extending from position + 264 to position + 3 of the full-length mdm2 transcript. Advantage was taken of a series of transformed rat embryo fibroblast [REFI cell lines, stably transfected with a chimeric construct containing a 2.9-kb EcoRI genomic DNA fragment from the 5' part of the mdm2 gene linked to the bacterial chloramphenicol acetyltranferase (CATI gene. The 2.9-kb fragment extends from a position of approximately -800 bp {relative to the first nucleotide of exon 1) down to the middle of intron 3 {Fig. 1A). In addition, these cell lines also harbor activated Ha-ras, as well as the temperature-sensitive p53 mutant p53val135. Shifting the growth temperature of these cells down to 32~ also leads to p53-mediated growth arrest, as well as a marked p53-dependent induction of CAT enzymatic activity . This induction reflects the activation of a p53-responsive promoter residing within the cloned genomic mdm2 DNA segment.
The sizes of the RNA fragments expected to arise as a result of the protection of the riboprobe by RNA from such cell lines are illustrated in Figure lB . Briefly, mRNA emanating from the upstream mdm2 promoter described previously (Fakharzadeh et al. 1991) , should protect exons 1-3 and yield a fragment of -262 nucleotides; mRNA initiated anywhere within intron 1 is expected to protect only exons 2 and 3 and yield a fragment of 149 nucleotides; mRNA starting within intron 2 should protect only exon 3 sequences and give rise to a fragment of 66 nucleotides; initiation within exon 2 should result in a protected fragment whose length will be anywhere between 66 and 149 nucleotides.
The actual protection pattem obtained with RNA from the rp-2.9md-CAT# 1 cell line is presented in Figure 1C . Two major protected fragments are detected. The larger is -260 nucleotides long, corresponding in size to a transcript containing exons 1, 2, and 3, probably emanating from the upstream (P1) promoter (Fig. 1B) . The rather low intensity of the band suggests that the 2.9-kb mdm2 genomic DNA fragment contains elements sufficient for driving basal transcription from P1. In addition, the failure to induce this band following shift of the cells to 32~ suggests that the transcriptional activity of P1 is not significantly regulated by p53.
The smaller protected fragment, whose levels are dramatically induced by wild-type p53 at 32~ is -147 nucleotides long. This size could be attributable to protection of exon 3 plus almost the entire exon 2. In that case, the corresponding transcript might initiate within exon 2, very close to its 5' end. The detection of such a transcript would confirm the existence of the putative internal p53-dependent promoter (P2) and place its position in very close proximity upstream to exon 2.
To determine unequivocally the initiation site (I2) of the P2-derived transcripts, RNase protection analysis (Fig. 1D, bold arrow, lane 5). These fragments are slightly shorter than the one resulting from the protection of the entire exon 2 by a synthetic c R N A (Fig. 1D, lane 2) . These data corroborated the conclusion that I~ is located within exon 2, very close to its 5' end. A similar analysis was performed Cold Spring Harbor Laboratory Press on February 5, 2014 -Published by genesdev.cshlp.org Downloaded from with RNA from cell line rp-l.9md-CAT# 1, harboring a 1.9-kb genomic mdm2 DNA fragment (EagI-EcoRI; Fig.   1A ). This 1.9-kb fragment begins within intron 1 and, hence, lacks P1 and I1; consequently, it is expected to give rise only to transcripts driven by Pz and initiating at 12. The results obtained with this cell line (Fig. 1D , lane 3) were essentially identical to those seen with the line containing the intact 2.9-kb region, further confirming that the protected -80-nucleotide bands represent authentic Pz-derived transcripts. As expected, the abundance of these transcripts was highly temperature dependent; far less RNA was produced in cells maintained at 37.5~ where p53val135 possesses very little wild-type p53 activity (lanes 4,61.
To establish definitively the position of I2, primer extension analysis was performed. Two staggered primers, complementary to sequences within the third exon of the mdm2 gene, were used. The 5' ends of these primers correspond to positions + 149 and + 173, relative to the first nucleotide of exon 2 {O1 and 02, respectively, Fig.  1E ). As a template for the reverse transcription reaction, we used RNA extracted from the rp-2.9md-CAT# 1 and rp-l.9md-CAT#l lines maintained at either 37.5~ or 32~ The abundance of the major extension products of both primers {marked by arrows in Fig. 1FI exhibits a clear dependence on the growth temperature of the cells. The sizes of the extended products imply that I2 is located at about the third nucleotide of exon 2 [ Fig. 1G} . Control experiments, using a synthetic full-length mdm2 mRNA as a template for primer extension, ruled out the possibility that the pattern in Figure 1F is attributable to premature termination by reverse transcriptase {data not shown}, thereby confirming the deduced position of lz. It is noteworthy that an AT-rich sequence, which may function as a TATA box, is located -20 bp upstream of 12 (Fig. 1G ).
In summary, we conclude that the first intron of the mouse mdm2 gene contains an authentic p53-responsive promoter and that the two adjacent p53-binding sites constitute bona fide promoter-proximal elements. These elements can mediate the induction of a distinct transcript of murine mdm2, starting at the third nucleotide of exon 2.
Activated wild.type p53 triggers P2 within the endogenous mdm2 gene
The experiments presented in Figure 1 were pedormed with chimeric constructs, containing defined segments of the mouse mdm2 gene. To validate the relevance of these findings, the analysis was extended to the nonmanipulated, endogenous mouse mdm2 gene in LTR6 cells.
The LTR6 cell line was established by transfection of p53-deficient M1 myeloid leukemia cells with the temperature-sensitive p53val135 mutant (Yonish-Rouach et al. 19911 . LTR6 cells undergo apoptosis in response to the induction of wild-type p53 activity following a shift to 32~ (Yonish-Rouach et al. 1991 , 1993 . RNA prepared from LTR6 cells before and after a temperature shift to 32~ was used in an RNase protection assay, in which the radiolabeled riboprobe was synthesized off of mdm2 cDNA {identical to the probe in Fig. 1B , CJ. Figure 2A illustrates the fragments expected to arise through protection of the probe by transcripts initiating from either P1 (262 and 196 nucleotides) or P2 (147 and 81 nucleotidesJ. The predictions take into account the existence of alternative mdm2 mRNA splicing variants devoid of exon 3, detected by virtue of their cloning from cDNA libraries [Fakharzadeh et al. 1991; Haines et al. 1994 ; Y. Barak and M. Oren, unpubl.I. These variants are not expected to be observed in the analysis of the mdm2-CAT chimeras {Fig. 1), which lack the splice acceptor site at the 3' end of intron 3. The results of the RNase protection analysis {Fig. 2BJ reveal that in the absence of functional wild-type p53 {parental M1 cells and LTR6 cells maintained at 37.5~ lanes 3 and 4, respectively}, only transcripts initiating at P1 {denoted F, for the sake of brevity} were detectable. On the other hand, activation of wild-type p53 at 32~ caused a marked induction of P2-derived transcripts (denoted X2} while not affecting the amount of Pl-derived mdm2 mRNA {lane 5). This pattern was not affected by exposure of the cells to IL-6, which slows down the p53-induced apoptotic process (Yonish-Rouach et al.
19911.
Hence, induction of wild-type p53 activity at 32~ activates transcription from P2 also in the context of the normal mdm2 gene. This proves further that P2 is a physiological p53-responsive promoter.
A similar assay was also performed with RNA from 3T3DM cells, which harbor an amplified mdm2 gene, and consequently overexpress MDM2 proteins (Fakharzadeh et al. 19911 . As seen in lane 2, these cells were found to contain large amounts of the Pl-derived, fulllength transcript but no detectable Pz-derived X2 transcripts. This is consistent with the notion that X2 is p53-dependent and that mdm2 amplification in 3T3DM cells leads to a complete inactivation of p53. It is noteworthy that in all RNA preparations, a relatively constant proportion of transcripts was devoid of exon 3, regardless of the initiation site. Agents that induce DNA damage, such as ionizing radiation, elicit stabilization and activation of the wildtype p53 protein (Maltzman and Czyzyk 1984; Kastan et al. 1991 Kuerbitz et al. 1992; Fritsche et al. 1993; Lu and Lane 1993} . As a result, the transcriptional activity of p53 is markedly elevated, inducing the expression of target genes such as gadd45 Zhan et al. 1993} , WAF1 (E. Gottlieb and M. Oren, unpubl.I, and mdm2 (Perry et al. 1993; Chen et al. 1994) . To find out whether P2 activity is induced in a p53-dependent manner also in response to DNA damage, RNase protection analysis was performed with RNA from derivatives of DA-1 cells. DA-1 is an interleukin-3 (IL3}-dependent cell line that expresses wild-type p53 (Gottlieb et al. 1994) . We have described previously the inactivation of the endogenous wild-type p53 in DA-1 cells, by means of infection with a retroviral vector encoding a negativedominant carboxy-terminal fragment of p53. The resultant cell population, termed DIDD, fails to undergo efficient apoptosis in response to either ionizing radiation or
1742

GENES & DEVELOPMENT
Cold Spring Harbor Laboratory Press on February 5, 2014 -Published by genesdev.cshlp.org Downloaded from IL-3 withdrawal (Gottlieb et al. 1994) . On the other hand, DA1 cells infected with a retrovirus encoding only the neomycin-resistance (neo) (DIN) continue to express functional wild-type p53 and retain a normal response to D N A damage and factor withdrawal.
RNA extracted from DIN and DIDD cells 3 hr after exposure to v-irradiation or sham treatment was analyzed using the m d m 2 cDNA-derived riboprobe described in Figures 1B and 2A . As seen in Figure 3 , irradiation of DIN cells resulted in a clear induction of the X2 transcript, giving rise to a series of protected bands of -1 4 7 nucleotides (cf. lanes 2 and 3). In contrast, no induction of X2 was observed in irradiated DIDD cells (cf. lanes 4 and 5), confirming that the activity of P2 is strictly dependent on the presence of functional wildtype p53. These data establish that P2 of m d m 2 is a D N A damage-inducible, p53-dependent promoter.
In addition to the activation of the P2 promoter, irradiated DIN cells also displayed a moderate increase in the amount of Pl-derived F transcripts (cf. lanes 2 and 3). This effect, too, appears to require functional wild-type p53; no parallel induction was seen in DIDD cells (lanes 4,5). The response of P1 in DA1 cells thus differs from that seen in LTR6 and r p -2 . 9 m d -C A T # 1 cells, where P1 appears to be totally unaffected by the activation of wildtype p53 (Fig. 1C and 2B ). This could be attributable ei- 
ther to cell type-specific differences or to the different manner by which p53 activation was achieved in each case.
The F and X2 transcripts of mdm2 display nonidentical in vitro translation profiles
The first in-frame AUG codon of murine mdm2 mRNA resides within exon 3 and is therefore present both in the full-length F transcript and in the p53-dependent X2 transcript (Fig. 4A) . Consequently, both transcripts formally have an identical coding potential. It is noteworthy, however, that this first AUG resides within the rather unfavorable sequence context CCAAUGU (Kozak 1986 ). This could potentially lead to inefficient translation initiation at this site and allow at least some of the translated polypeptides to initiate at downstream codons. Analysis of cellular MDM2 proteins has revealed To address this issue, we constructed a series of in vitro transcription vectors, capable of directing the synthesis of different RNA variants of mouse mdm2; the structure of the various transcripts and the positions of the first four in-frame AUG codons are illustrated schematically in Figure 4A . In addition to F and X2, these synthetic transcripts included an altematively spliced variant devoid of of the third exon and thus lacking the first two in-frame AUG codons (D), a 5' truncated transcript initiating downstream to the second AUG codon (B), and a variant lacking exons 1 and 2, which had been mutated so that its first in-flame AUG now resides within an optimal consensus translation initiation context (KC). A stretch of 15 nucleotides, contributed by the vector, is present at the 5' end of all these synthetic mdm2 RNA molecules.
The various synthetic mdm2 transcripts were next subjected to standard in vitro translation reactions in a rabbit reticulocyte lysate. Two major classes of translation products could be detected in these reactions (Fig.  4B) . The B and D transcripts, both of which lack the first two in-flame AUG codons (Fig. 4A) , yielded a faster migrating MDM2 protein (Fig. 4B, lanes 1,2) . It can therefore be deduced that this form represents translational initiation at an internal AUG codon, presumably the one at position + 50 (Fig. 4A) . On the other hand, the KC transcript was translated primarily into a slower migrating form of MDM2 (Fig. 4B , lane 5); in addition, it was translated more efficiently than all other species. Both these features are consistent with the fact that KC has been designed to optimize initiation at the first in-frame AUG. On the basis of the patterns obtained with these control mdm2 transcripts, the slower and faster migrating translation products of mdm2 can be attributed to initiation at positions + 1 (or + 6) and + 50, respectively. When the F and X2 transcripts were translated under the same reaction conditions (-5 pmoles of RNA per reaction), a striking difference between the translation products of each was observed (Fig. 4B, cf. lanes 3 and 4) . Each of the RNA species gave rise to the same two classes of MDM2 polypeptides. However, although F was translated predominantly into the shorter MDM2 polypeptides, the absence of exon 1 in the X2 transcript greatly facilitated initiation at the first in-flame AUG. Consequently, X2 was translated into approximately equal amounts of the shorter and the longer MDM2 polypeptides. Thus, the p53-dependent (P2-derived) X2 transcripts of mdm2 exhibit an altered translation potential, despite retaining the same coding region in common with the constitutive (Pl-derived) F transcripts.
In vivo expression patterns of MDM2 protein variants
It was of interest to determine whether the potential for altemative use of translation initiation sites is reflected in the pattern of MDM2 proteins expressed in intact murine cells. To that end, unlabeled extracts from several cell types were immunoprecipitated, resolved by SDS-PAGE, blotted, and probed with a polyclonal serum specific for MDM2. In the cell types examined, the results revealed the presence of a longer MDM2 polypeptide as well as of a faster migrating band (Fig. 5, lanes 1--4,6 ). The latter band could be resolved further into two separate polypeptides in some of the immunoprecipitated extracts (lanes 1,2) . The main MDM2 bands observed in intact cells exhibited electrophoretic mobilities indistinguishable from those of the alternative in vitro translation initiation products (lane 8). This suggests that these polypeptides are generated through the usage of alternative in-frame initiator AUGs, similar to those utilized by the reticulocyte lysate.
As expected from the RNA data shown in Figure 2 , much more total MDM2 protein was made in LTR6 at 32~ in the absence or presence of IL6, than in the same cells or the parental M1 cells at 37.5~ (cf. lanes 3 and 4 with lanes 1 and 2). On the other hand, at least under the conditions used in this experiment, no marked differences were observed with regard to the ratio between the longer and shorter polypeptides in the various cells. Thus, although LTR6 cells contain primarily F transcripts at 37.5~ and X2 transcripts at 32~ (Fig. 2, lanes Figure 5. Analysis of MDM2 polypeptides from intact cells. Extracts from cell lines maintained under the conditions indicated at the top were immunoprecipitated using either anti-MDM2 polyclonal serum (lanes 1-4,6 ) or the anti-p53 monoclohal antibody pAb421 (lanes 5,7). Immunoprecipitated material, as well as in vitro translation products of the synthetic F transcript (see Fig. 4B , lane 3), were subjected to Western blotting and probed with anti-MDM2 polyclonal serum. The deduced amino acid positions of the translation initiation sites are indicated for each polypeptide. The 105-kD band observed above the MDM2 polypeptides represents nonspecific cross-reactivity, precipitated also by control antibodies (data not shown). 4,5), the patterns of MDM2 polypeptides were qualitatively quite similar at both temperatures (Fig. 5, lanes  2,3) ; at best, there was only a mild increase in the relative proportion of the larger MDM2 polypeptide (initiated at + 1) at 32~ A similar distribution of MDM2 polypeptides was also seen in 3T3DM cells (lane 6), which produce large amounts of the F transcript and practically lack X2 RNA (see Fig. 2B, lane 2) . The slower migrating band (-105 kD) observed above the larger MDM2 polypeptide represents nonspecific cross-reactivity and is also brought down by irrelevant control antibodies (data not shownl.
In addition, we performed a functional analysis of the various MDM2 polypeptides by testing their ability to coprecipitate with p53, employing a monoclonal antibody against the latter in the immunoprecipitation step of the analysis. Based on the localization of the p53-binding site to the most amino-terminal portion of MDM2 Oliner et al. 1993) , an internally initiated MDM2 protein beginning at the fiftieth in-frame codon is expected not to bind p53. The results (Fig. 5 , lanes 5,7) demonstrate clearly that this is the case; only the longer MDM2 polypeptide could be coprecipitated with p53, suggesting that the shorter polypeptide is missing its amino terminus, most likely as a result of internal translation initiation.
In conclusion, the results presented in Figure 5 argue strongly that the various forms of m d m 2 mRNA are subject to alternative translation initiation also in intact cells. However, under these conditions, the first in-frame AUG appears to be employed preferentially also for the translation of the F transcript.
The in vitro translation patterns of mdm2 depend on the amount of input RNA
A possible explanation for the quantitative variance between in vitro and in vivo translation patterns of the F and X2 forms of m d m 2 RNA could be a different ratio between the input RNA and limiting components of the translation machinery. Standard in vitro translation reactions employ a large excess of specific RNA relative to the situation in vivo. It is conceivable that the translatability of the various m d m 2 transcripts could be affected by the ratio between the amount of mRNA and that of available translation factors. To address this possibility, in vitro translation reactions were programmed with lower mRNA inputs: 1 or 0.1 pmole per assay. The use of 1 pmole of RNA resulted in a significant improvement of translational initiation at the first AUG of both the F and the X2 transcripts (Fig. 6A, lanes 1,2) . Nevertheless, the ratio between full-length MDM2 proteins (initiated at codon + 1) and polypeptides initiated at internal AUGs remained significantly higher with X2 than with F. The &XE transcript, which differs from F only by the presence of a small internal deletion within the first exon (Fig.  4A) , yielded a translation pattern indistinguishable from that of the F RNA (Fig. 6A, lane 3) , lending further support for the reproducibility of these results. The products of the D and KC transcripts were both as expected ( 6A, lanes 4,5), except that KC now yielded almost exclusively the full-length MDM2 protein. A further 10-fold dilution of the RNA in the translation mixture led to an even more efficient initiation at the first AUG of both F and X2, making the difference between the translation profiles of both less pronounced (Fig. 6B ). Yet, even under those very nonstandard conditions, more of the fulllength protein was produced when the reaction was programmed with X2, relative to F (Fig. 6B, cf . the upper band in lanes 2 and 3). It is noteworthy that in Figure 6 one can also observe a smaller polypeptide that most probably represents initiation at the fourth in-frame AUG (position + 62).
These data suggest further that the F and X2 types of mdm2 transcripts bear a potential for alternative translational initiation, at least when programming a reticulocyte lysate. The manifestation of this potential becomes more pronounced under conditions of RNA excess, suggesting that a titratable factor may be required for efficient initiation at the first AUG. The data presented above suggest that the presence of exon 1 at its 5' end may render the Px-derived, F form of mdm2 mRNA more dependent on the availability of this putative factor.
Discussion
The present study demonstrates that transcription of the mouse mdm2 gene can emanate from two distinct promoters. This feature confers upon mdm2 the ability to be strongly inducible by p53, as well as to be expressed at significant levels in the absence of p53.
Activation of murine mdm2 transcription by p53 is achieved through an internal promoter, whose activity is strictly dependent on wild-type p53. This promoter, termed here P2, is practically silent in cells that do not express wild-type p53 or express only basal levels of the protein (e.g., unirradiated DIN cells; Fig. 3) . However, when the cell is confronted with high levels of wild-type p53, P2 becomes strongly activated. This activation not only occurs in response to the forced overexpression of transfected p53 but also when the endogenous p53 is induced by DNA damage. Hence, P2 represents a specific natural target for trans-activation by wild-type p53.
In contrast, the constitutive mdm2 promoter P1 does not require wild-type p53 to become functional. Consequently, p53-deficient cells express low but clearly detectable levels of mdm2 mRNA and of the corresponding protein products, the production of which is under the control of P1. The effect of wild-type p53 overexpression on P1 varies with the particular cell system. The REFderived cell line rp-2.9md-CAT#l, as well as the myeloid LTR6 cells, harbor the transfected temperaturesensitive p53 mutant p53val135. In both cases, activation of p53 at the permissive temperature does not exert any measurable effect on transcription from PI. On the other hand, potentiation of endogenous wild-type p53 by ionizing radiation in DIN cells leads, in parallel with the dramatic induction of P~, also to a moderate increase in transcription from P~ (see Fig. 3 ). Hence, apart from being integral components of the p53-dependent P2 promoter, the p53 REs located in front of exon 2 also sometimes do function as an intronic enhancer, acting to augment transcription from P1.
The structural features of P~, as well as its mode of regulation, still remain to be determined. It is conceivable that Px may contain response elements for other signals, unrelated to p53, which may also contribute to modulation of mdm2 gene expression under various conditions.
An additional p53 target, the gadd45 gene, also possesses an intronic p53-binding site . It would be of interest to determine whether gadd45, too, contains an internal p53-activatable promoter or whether its p53 RE serves only as a bona fide downstream enhancer.
The first two exons of murine rndm2 do not include protein-coding sequences, and the transcript directed by P2 differs from the constitutive, Pl-directed transcript by the mere absence of 5' noncoding sequences. Hence, both types of transcripts are expected to generate the same translation products. It therefore appeared intriguing that p53 needs to selectively induce transcription from P2, rather than merely serve as an enhancer toward the potentiation of P~. A partial explanation is provided by the in vitro translation experiments (Figs. 4 and 6) , which show clearly that the presence of distinct 5' ends can dictate the differential usage of in-frame translation initiation codons. This possibility becomes even more appealing in view of the fact that the products of this alternative translation initiation differ from each other with regard to their ability to bind p53. Thus, initiation at the first (+ 1) or second (+6) AUG will yield p53-binding polypeptides, whereas initiation at more downstream AUGs should give rise to forms of MDM2 that cannot associate with p53.
In the F transcript, whose synthesis is, by and large, unaffected by p53, initiation at the first AUG codon appears to be particularly context dependent. Under conditions of excess RNA, its translation in vitro yields mainly amino-terminally truncated MDM2 variants, which cannot bind to p53. However, when diluted, this transcript regains the capacity to encode a full-length, p53-binding MDM2 protein. This phenomenon may imply that a titratable factor is required for efficient translation initiation at the upstream AUG of mdm2 mRNA.
Although this requirement appears to be very strict for RNA directed by P1, it may be more relaxed for the p53-induced X2 transcript. As a result, translation of X2 gives rise to a higher ratio of full-length to amino-terminally truncated MDM2 polypeptides than translation of F, as well as to significantly greater absolute amounts of the full-length forms (see Fig. 4 ).
The MDM2 protein contains several canonical sequence motifs, such as metal-binding fingers and acidic trans-activation-like domains (Fakharzadeh et al. 1991) , which are distinct from its p53-binding region Oliner et al. 1993) . It is conceivable that MDM2 products may fulfill additional biochemical functions, distinct from their role in the p53 autoregulatory feedback loop Wu et al. 1993) . One may therefore envisage situations where P1 is activated by signals that bear no direct relevance to p53. If this always resulted in accumulation of p53 binding, full-length MDM2 polypeptides, p53 function could have been compromised even under conditions when this may be disadvantageous for the cell. This problem can potentially be circumvented through the mechanism suggested by our data, namely the usage of internal translation initiation sites to generate amino-terminally truncated MDM2 polypeptides. Such polypeptides may not bind p53 but will retain all other structural domains required for the additional putative functions of the protein.
There is also another mechanism for the production of similar amino-terminally truncated MDM2 proteins. Analysis of mouse mdm2 cDNA clones from various sources provides compelling evidence for the existence of an alternatively spliced variant, devoid of exon 3 (Fakharzadeh et al. 1991; Y. Barak and M. Oren, unpubl.;  see also the cDNA variant designated D in Fig. 4A) . A limited amount of such spliced transcripts is also evident in the data presented in Figures 2 and 3 (fragments of 196 nucleotides and 81-83 nucleotides). This transcript can encode only an amino-terminally truncated MDM2 protein, lacking half of its p53-binding domain (Fig. 4B, lane 2) , and incapable of binding p53 (Haines et al. 1994 ; see also Fig. 5) . Thus, increased levels of p53 nonbinding MDM2 proteins can potentially be achieved either by providing conditions that favor translational initiation at internal AUG codons or by increasing the proportion of transcripts from which exon 3 is spliced out.
In parallel, our findings also imply a mechanism for enhanced production of full-length, p53-binding forms of MDM2 proteins. Such outcome can be achieved through the preferential activation of P2, as is the case for ceils exposed to the presence of activated wild-type p53. As suggested by the data in Figures 4 and 6 , the resultant X2 transcript is translated into full-length MDM2 more efficiently than the constitutive F transcript. There may be conditions where the putative titratable factor necessary for efficient initiation at the first in-frame AUG becomes limiting. Under such conditions, an induced increase in mdm2 mRNA through Pt might have resulted in a large number of p53 nonbinding MDM2 polypeptides, incapable of participating in the p53 feedback loop Wu et al. 1993 ). Activation through P2 will give rise to a form of mdm2 mRNA that can be translated efficiently into full-length protein even under such less favorable conditions. Hence, P2 may serve to maintain an efficient p53 feedback loop under a wide spectrum of cellular contexts.
In conclusion, the present study reveals a novel facet of the complex and very dynamic interplay between p53 and mdm2. The precise functions of each form of MDM2 protein, as well as the mechanisms that dictate the ratio between initiation at the first AUG and at the more downstream AUGs, still remain to be investigated in more detail.
Materials and methods
Cell lines
Lines rp-md2.9-CAT#1 and rp-mdl.9-CAT#1 are derived from primary REFs, transformed by cotransfection of activated Ha-ras, the temperature-sensitive p53 mutant p53va1135, and a plasmid containing either a 2.9-or a 1.9-kb genomic mclm2 DNA fragment, respectively, upstream of a promoterless CAT gene . The 2.9-kb mdm2 fragment extends from -0.8-kb upstream of the reported first nucleotide of mdm2 mRNA to the middle of the third intron (see Fig. 1A ). The 1.9-kb fragment was generated from the 2.9-kb fragment by deletion of the 5' -1.0 kb {from EcoRI to EagI; Juven et al. 1993) . 3T3DM is a transformed derivative of NIH-3T3 cells carrying multiple copies of an amplified mdm2 gene (Cahilly-Snyder et al. 1987 ). All cells were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 5% or 10% FCS.
M1 is a p53-deficient murine myeloid leukemic cell line (Yonish-Rouach et al. 1991) . LTR6 cells were derived from M1 by stable transfection of p53val135 (Yonish-Rouach et al. 1991) . These cells were maintained at 37.5~ in RPMI medium supplemented with 10% FCS. Where appropriate, cells were shifted to 32~ for 12-13 hr in the presence of 8 ng/ml of IL-6, or for 8-9 hr in the absence of IL-6.
DIN and DIDD are cell pools obtained by retroviral infection of the DA-1 lymphoid line (Gottlieb et al. 1994) . DIN cells harbor an integrated provirus expressing neo. The retrovirus used for generating DIDD expresses, in addition to the neo gene, the carboxy-terminal oligomerization domain of p53; this domain was shown previously to inhibit p53 activity in a dominant-Cold Spring Harbor Laboratory Press on February 5, 2014 -Published by genesdev.cshlp.org Downloaded from negative fashion (Shaulian et al. 1992) . Cells were maintained in DMEM+ 10% FCS in the presence of IL-3. Where indicated, cells were exposed to 500 fads of radiation from an isotopic cobalt source ( + ~/).
Ribonuclease protection assays
Assays were performed essentially as described (Melton et al. 1984) . Cellular RNA was prepared by the RNAzol method. In vitro transcription plasmids were based on the commercial vector pSL301 (Invitrogen). Radiolabeled antisense riboprobes were generated by transcription with T7 RNA polymerase. DNA fragments used as templates for transcription include a PCRderived murine mdm2 eDNA fragment extending from position + 264 to position + 3 of the published sequence (Fakharzadeh et al. 1991) and an ApaI-NsiI murine mdm2 genomic DNA fragment. Synthetic RNA used as control for hybridization with the probes was derived by transcribing either the full-length mdm2 eDNA (cRNA) or an -900-bp EagI-XhoI mdm2 genomic DNA fragment (gRNA). Hybridization was typically carried out overnight at 45-50~ using 10-40 ~g of total cellular RNA and 2x l0 s cpm of the appropriate riboprobe. RNase digestion was performed by incubation with a mixture of RNase A and RNase T1 (Sigma) for 30-60 min at 25-32~ Nuclease-resistant fragments were resolved on 6% polyacrylamide-urea gels.
Primer extension
Total cellular RNA (20 ~g) was hybridized overnight, at room temperature, to end-labeled oligonucleotides (1 x 10 6 cpm/reaction) in 3 M NaC1. Extensions were carried out for 90 min at 42~ followed by 30 min at 52~ using AMV reverse transcriptase and nonradioactive deoxynucleotides. Extension products were resolved on 6% polyacrylamide-urea gels. The sequences of the oligonucleotide primers used are 5'-GCTG-GAATCTGTGAGGTG-3' (O1) and 5'-CTGCCTCGAGTCTC-TTGTTCCGAAGCTGG-3' (02}.
In vitro transcription~translation
The indicated mdm2 eDNA fragments were constructed into the EcoRI site of plasmid pGEM1 (Promega). RNA was transcribed using T7 RNA polymerase, and template DNA was then hydrolyzed using RNase-free DNase (Worthington). Following phenol and chloroform extraction, RNA was differentially precipitated in the presence of ammonium acetate. The RNA concentration in each sample was determined by OD26 o measurement and normalized to molar concentration according to the calculated size of each transcript. The indicated amounts of RNA were translated in a rabbit reticulocyte lysate (Promega) under the conditions recommended by the manufacturer. Translation products were resolved on 7.5% polyacrylamide-SDS gels.
Antibodies, immunoprecipitation, and Western blotting
Antibodies used include the anti-p53 monoclonal antibody pAb421 (Harlow et al. 1981) and an anti-MDM2 rabbit serum . Immunoprecipitations were carried out as described previously (Maltzman et al. 1981) . Immunoprecipitated proteins were resolved by 7.5% polyacrylamide-SDS gels. Western blots were performed as described , except that nitrocellulose membranes were used.
